Inadequate Diagnostic Standards in ADHD Research May Undermine Adult Mental Health Treatment
Millions of adults globally are diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) each year, yet a growing body of research suggests that the foundation for many of these diagnoses—and the treatments based on them—may be alarmingly unstable.
A new study by researchers from the University of Copenhagen and the University of São Paulo highlights serious methodological flaws in clinical trials that may be jeopardizing the health and well-being of adult ADHD patients.
Although ADHD was originally diagnosed in children based on observable behaviors, diagnosing the condition in adults relies heavily on subjective self-reporting, such as difficulties with focus or impulsivity.
These adult-specific symptoms often overlap with other mental health disorders, such as depression, bipolar disorder, or schizophrenia—making accurate diagnosis far more complex and critically important.
However, the recent study, which analyzed 292 randomized controlled trials (RCTs)—considered the gold standard in clinical research—found that 50% of the studies failed to rule out other psychiatric conditions before enrolling subjects. This oversight means that some participants may have been misdiagnosed, which undermines both the validity of the research and the reliability of treatments developed from it.
“Many adults are now seeking ADHD diagnoses, often influenced by content on social media,” says Dr. Igor Studart, one of the study’s authors. “But without robust diagnostic procedures, we risk mislabeling individuals and giving them inappropriate care.”
The implications for public health are significant. If treatments are tested on poorly diagnosed subjects, it becomes nearly impossible to determine whether the interventions are truly effective for ADHD or if they are targeting symptoms of entirely different disorders.
Adding to the concern, the study found that 61% of the trials did not disclose who performed the diagnostic assessments, and only 35% clearly stated that a qualified psychiatrist or psychologist made the diagnosis. In some cases, the researchers discovered that participants diagnosed themselves—or were assessed using computerized tools with no human oversight.
“This is deeply concerning,” says Professor Julie Nordgaard, a psychiatrist and co-author of the study. “Mental health diagnoses must be made by trained professionals using standardized criteria. Otherwise, we are building treatment guidelines on shaky ground.”
In trials where participants had co-occurring mental disorders, it was often unclear how those additional diagnoses were factored into the study’s analysis, further complicating the results.
“We may be giving treatments to people who don’t actually have ADHD, or worse, denying effective treatment to those who do,” says Associate Professor Mads Gram Henriksen. “This is not just a research issue—it’s a public health risk.”
As adult ADHD diagnoses continue to rise globally, the researchers are calling for a stricter, more uniform diagnostic approach in clinical research. Accurate diagnosis is critical not just for the integrity of scientific findings, but for ensuring that patients receive care that truly meets their needs.
“In psychiatry, consistency in diagnosis is essential,” Nordgaard emphasizes. “Without it, we can’t trust research findings, and ultimately, we fail the very people the healthcare system is meant to help.”
The study serves as a wake-up call for both the scientific community and public health systems. Ensuring that mental health diagnoses like ADHD are made carefully and professionally is not merely a technical detail—it’s a crucial step toward safeguarding patient outcomes and delivering effective, evidence-based care.
Related topics:
